University of Michigan Health System - link
Department of Internal Medicine - link
NEPHROLOGY
search this site
 
 
Vahakn B. Shahinian, M.D., M.S.

Research Summary:

Patterns and health outcomes of gonadotropin-releasing hormone agonist use for the treatment of prostate cancer using the Surveillance, Epidemiology, and End-Results (SEER)-Medicare linked registry.

Link to PubMed Citations

Selected Publications:

Shahinian VB , Kuo Y-F, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. Journal of the National Cancer Institute 2006;98:839-845. (corresponding author)

Shahinian VB , Kuo Y-F, Freeman JL, Goodwin JS. Risk of the “Androgen Deprivation Syndrome” in men receiving androgen deprivation for prostate cancer. Archives of Internal Medicine 2006;166:465-471. (corresponding author)

Shahinian VB , Kuo Y-F, Freeman JL, Orihuela E, Goodwin JS. Increasing Use of Gonadotropin-Releasing Hormone Agonists for the Treatment of Localized Prostate Cancer. Cancer 2005;103:1615-1624. (corresponding author)

Shahinian VB , Kuo Y-F, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. New England Journal of Medicine 2005;352:154-164. (corresponding author)

Agraharkar M, Cinclair R, Kuo Y-F, Daller J, Shahinian V. Risk of Malignancy with Long-term Immunosuppression in Renal Transplant Recipients. Kidney International 2004;66:383-389.

Khakhar AK , Shahinian VB, House AA, Muirhead N, Hollomby DJ, Leckie SH, McAlister VC, Chin JL, Jevnikar AM, Luke PP. The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome. Transplantation Proceedings. 2003;35(2):862-3.

Shahinian VB , Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS , Hollomby DJ, House AA. Epstein-Barr virus seronegativity is a risk factor for late onset post-transplant lymphoproliferative disorder in adult renal allograft recipients. Transplantation 2003;75:851-856.

Edwards C, House A, Shahinian V, Knoll G. Sirolimus-based immunosuppression for transplant associated thrombotic microangiopathy. Nephrology, Dialysis, Transplantation 2002; 17: 1524-1526.

Shahinian VB, Rajaraman S, Borucki M, Hollander M, Ahuja TS. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. American Journal of Kidney Diseases 2000; 35: 884-888.

Ahuja TS, Borucki M, Funtanilla M, Shahinian VB, Hollander M, Rajaraman, S. Is the prevalence of HIV nephropathy decreasing? American Journal of Nephrology 1999; 19:655-659.

 
     
   

U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright Regents of the University of Michigan
Template developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index